A study to assess the clinical and economic efficacy of joint vaccine prophylaxis with conjugated pneumococcal vaccine and influenzal vaccine in patients with chronic obstructive pulmonary disease
Latest Information Update: 06 Jul 2020
At a glance
- Drugs Influenza virus vaccine (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Influenza virus infections; Pneumococcal infections
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 20 May 2020 Results presented at the 116th International Conference of the American Thoracic Society
- 03 Mar 2020 New trial record